Dr. Kimberly McCormick is Senior Vice President Regulatory Affairs and Medical Writing. Kim brings over 25 years of global regulatory expertise and experience leading cross-functional teams across multiple therapeutic areas. Kim previously held the role of Chief Regulatory Affairs and Quality Assurance Officer at Marinus Pharmaceuticals where she established and grew the regulatory and quality organizations and was responsible for global regulatory interactions. Prior to Marinus, Kim held regulatory positions of increasing seniority at Shire, Pfizer and Wyeth. Kim has managed multiple worldwide developmental projects for regulatory in neuroscience therapeutic areas, including rare/orphan disease products.
Kim received her Doctor of Pharmacy degree from the University of the Sciences of Philadelphia.
